The effectiveness of COVID-19 vaccines against severe cases and deaths in Brazil from 2021 to 2022: a registry-based study

BACKGROUND: Brazil started the COVID-19 mass vaccination in January 2021 with CoronaVac and ChAdOx1, followed by BNT162b2 and Ad26.COV2.S vaccines. By the end of 2021, more than 317 million vaccine doses were administered in the adult population. This study aimed at estimating the effectiveness of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos, Cleber Vinicius Brito dos, Valiati, Naiara Cristina Morais, Noronha, Tatiana Guimarães de, Porto, Victor Bertollo Gomes, Pacheco, Antônio Guilherme, Freitas, Laís Picinini, Coelho, Flávio Codeço, Gomes, Marcelo Ferreira da Costa, Bastos, Leonardo Soares, Cruz, Oswaldo Gonçalves, Lana, Raquel Martins, Luz, Paula Mendes, Carvalho, Luiz Max Fagundes de, Werneck, Guilherme Loureiro, Struchiner, Claudio José, Villela, Daniel Antunes Maciel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010656/
https://www.ncbi.nlm.nih.gov/pubmed/36936517
http://dx.doi.org/10.1016/j.lana.2023.100465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010656/
https://www.ncbi.nlm.nih.gov/pubmed/36936517
http://dx.doi.org/10.1016/j.lana.2023.100465

Ejemplares similares